Astria Therapeutics Unveils New Stock Option Inducement Plan for Incoming Employees

Reuters
07-03
Astria <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Unveils New Stock Option Inducement Plan for Incoming Employees

Astria Therapeutics Inc. has announced the granting of stock options to purchase 119,860 shares of its common stock as part of the 2022 Inducement Stock Incentive Plan. This initiative is designed for individuals who were not previously employed by the company. The options, granted on July 1, 2025, come with an exercise price of $5.43 per share, reflecting the closing price on the grant date. The vesting schedule spans four years, with 25% of the shares vesting on the first anniversary of the employee's start date and the remainder vesting monthly over the subsequent 36 months, contingent on continued employment with Astria. These options are governed by the 2022 Inducement Stock Incentive Plan and an award agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Astria Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250702015833) on July 02, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10